Leaving infectious diseases untreated is encouraging usage of the antibiotics. Additionally, poor regulations for antibiotic supply hamper efforts for reducing usage of antibiotics mainly in developing countries. The study in Trials suggests these findings from a research by a team at the University of Warwick.
Dr. Marco J Haenssgen demonstrates the impacts of contextual factors on clinical trials. The study suggests that factors such as health policies have an impact on medical practices and clinical trials.
The researchers recorded such factors and suggested effective management of these major issues in healthcare. Some research collaborations among social and medical sciences help to tackle the major issues including drug resistance.
Suggested Solutions in the Study:
Despite the guidance provided by test manufacturers, the healthcare providers are prescribing the antibiotics for the treatment of deadly infections. Additionally, to avoid revisits, the primary health centers are avoiding the test and patients are more ignorant toward results. Also, self-prescription of antibiotics from local stores are making the regulations less effective.
The population in the developing countries is more likely to be ignorant toward the tests. Thus, the study argues over the increasing awareness level among the targeted population.
The World Health Organization (WHO) named ignorance toward diagnostic biomarker tests as one of the serious threat to healthcare.
Dr. Haenssgen said this study was an example of context affected clinical adherence. Also, the doctors being an oversupply of antibiotics for avoiding the surplus medicines in the treatment of infection.
